Eyes Down For British American Tobacco plc Results

We should see improving first-half margins for British American Tobacco plc (LON: BATS).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

british american tobacco / imperial tobaccoResults from British American Tobacco (LSE: BATS) (NYSE: BTI.US) are showing something of a trend — falling global consumption of the noxious vegetation, but rising profits.

That’s because of a transition away from selling increasing volumes of low-margin products to poor people and towards selling higher-margin upmarket brands to the increasingly affluent markets of the world.

Last year

Final results for 2013 illustrated the change well. Cigarette volumes fell 2.7% to 676 billion with total tobacco volumes down 2.6%, and revenue was flat — but adjusted earnings per share (EPS) gained 6% at actual exchange rates and 10% at constant rates, and the company was able to boost its dividend by 6%.

We also heard that sales volumes of the firm’s Global Drive brands, that is those upmarket brands that generate more profit, grew by 1.9%. And so much cash was generated that £1.5bn was invested in buying back 44 million shares.

And that was an extension of the previous year — 2012 saw a 1.6% fall in volumes, a 7% rise in adjusted EPS, a 7% hike to the dividend, a 3% growth in Global Drive volumes, and 38.9 million shares bought back for £1.25bn.

First quarter

The last we heard from British American Tobacco was in April, in the from of a first-quarter update. Headlined “On Track For Another Good Year“, the report repeated the familiar story — total tobacco volumes down 1.1%, but Global Drive brand volumes up 6.3%!

Chief executive Nicandro Durante was moved to say “I remain confident of delivering consistent growth in earnings in constant currency terms, which we will recognise with an increase in the dividend“.

We are, then, all set up for this year’s first-half figures, which should be with us on Wednesday 30 July.

It might be slightly surprising that analysts are predicting a 2% fall in EPS for the full year, but the company is being hit by currency movements and a strong pound at the moment — revenue was actually down 12% at Q1 time at current exchange rates, but up 2% at constant rates.

Rising dividends

And the pundits are expecting a 2.8% rise in the dividend this year, to yield 4.1% on a share price of 3,524p.

The shares are on a forward P/E of 16.5, but with EPS expected to recover next year it would drop to around 15 — that’s only slightly above the FTSE 100’s average of 14, but British American’s dividend yield is significantly ahead of the index average.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft has no position in any shares mentioned. The Motley Fool has no position in any of the shares mentioned.

More on Investing Articles

Light bulb with growing tree.
Investing Articles

3 top investment trusts that ‘green’ up my Stocks and Shares ISA

I’ll be buying more of these investment trusts for my Stocks and Shares ISA given the sustainable and stable returns…

Read more »

Investing Articles

8.6% or 7.2%? Does the Legal & General or Aviva dividend look better?

The Aviva dividend tempts our writer. But so does the payout from Legal & General. Here he explains why he'd…

Read more »

a couple embrace in front of their new home
Investing Articles

Are Persimmon shares a bargain hiding in plain sight?

Persimmon shares have struggled in 2024, so far. But today's trading update suggests sentiment in the housing market's already improving.

Read more »

Market Movers

Here’s why the Unilever share price is soaring after Q1 earnings

Stephen Wright isn’t surprised to see the Unilever share price rising as the company’s Q1 results show it’s executing on…

Read more »

Investing Articles

Barclays’ share price jumps 5% on Q1 news. Will it soon be too late to buy?

The Barclays share price has been having a great time this year, as a solid Q1 gives it another boost.…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

The AstraZeneca share price lifts 5% on a top-and-bottom earnings beat

The AstraZeneca share price reached £120 today and helped push the FTSE 100 higher. Would I still buy this flying…

Read more »

Young black woman using a mobile phone in a transport facility
Market Movers

Meta stock slumps 13% after poor results. Here’s what I’ll do

Jon Smith flags up the reasons behind the fall in the Meta stock price overnight, along with his take on…

Read more »

Young Caucasian girl showing and pointing up with fingers number three against yellow background
Investing Articles

3 FTSE stocks I wouldn’t ‘Sell in May’

If the strategy had any merit in the past, I see no compelling evidence it's a smart idea today. Here…

Read more »